====== Bisphenol F 50μM R08 exp457 ====== ==== Mechanism of Action ==== BPA analog and substitute, endocrine disrupter * **Class / Subclass 1:** Environmental Stresses / Industrial Chemical ==== Technical Notes ==== * **PubChem Name:** %%4,4'-Methylenediphenol%% * **Synonyms:** N/A * **CAS #:** 620-92-8 * **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/12111|12111]] * **IUPAC:** %%4-[(4-hydroxyphenyl)methyl]phenol%% * **INCHI Name:** InChI=1S/C13H12O2/c14-12-5-1-10(2-6-12)9-11-3-7-13(15)8-4-11/h1-8,14-15H,9H2 * **INCHI Key:** PXKLMJQFEQBVLD-UHFFFAOYSA-N * **Molecular Weight:** 200.23 * **Canonical SMILES:** C1=CC(=CC=C1CC2=CC=C(C=C2)O)O * **Isomeric SMILES:** N/A * **Molecular Formula:** C13H12O2 {{:chemogenomics:structures:chem-0267.svg?nolink}} * **Supplier Name:** Ark Pharm Inc. * **Catalog #:** AK122333 * **Lot #:** WG0092170-160531001 * **HRMS (ESI-TOF) m/z:** (M-H)- Calcd for C13 H12 O2 199.07645; found 199.07755 * **Platform ID:** Bisphenol_F * **Min:** -11.8847; **Max:** 7.7151 {{:chemogenomics:dose_response:dr_418.png?nolink&500 |}} \\ \\ \\ \\ |< 300px 100px 200px >| ^ IC ^ Concentration (µM) ^ | IC10 |N/A | | IC20 |N/A | | IC30 |N/A | | IC40 |N/A | | IC50 |N/A | | IC60 |N/A | | IC70 |N/A | | IC80 |N/A | | IC90 |N/A | \\ ==== Screen Summary ==== * **Round**: 08 * **Dose**: 50µM * **Days of incubation**: 8 * **Doublings**: 5.5 * **Numbers of reads**: 14290606 ==== Screen Results ==== ^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^ |4/0|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/Bisphenol_F_50uM_Round-8_exp457.txt|Scores]]|||||| {{:chemogenomics:cranks_plots:exp457.png?nolink}} ^Gene^CRANKS Score^FDR^ |[[:human_genes:A:ALG9|ALG9]]|-3.72|<0.01| |[[:human_genes:T:TMEM189|TMEM189]]|-2.97|<0.01| |[[:human_genes:S:SCD|SCD]]|-2.93|0.03| |[[:human_genes:V:VPS25|VPS25]]|-2.84|0.27| |[[:human_genes:O:ORC3|ORC3]]|-2.64|0.04| |[[:human_genes:T:TPRKB|TPRKB]]|-2.56|0.09| |[[:human_genes:A:ACSL4|ACSL4]]|-2.52|0.10| |[[:human_genes:K:KDSR|KDSR]]|-2.51|0.07| |[[:human_genes:C:CAPRIN2|CAPRIN2]]|-2.46|0.07| |[[:human_genes:Z:ZNF708|ZNF708]]|-2.46|0.15| |[[:human_genes:T:TSSC1|TSSC1]]|-2.36|0.10| |[[:human_genes:A:ADIPOR2|ADIPOR2]]|-2.33|0.10| |[[:human_genes:A:ARL1|ARL1]]|-2.31|0.10| |[[:human_genes:S:SCYL1|SCYL1]]|-2.30|0.15| |[[:human_genes:N:NPRL3|NPRL3]]|-2.30|0.22| |[[:human_genes:C:CEPT1|CEPT1]]|-2.29|0.11| |[[:human_genes:F:FAF2|FAF2]]|-2.27|0.23| |[[:human_genes:V:VPS52|VPS52]]|-2.22|0.51| |[[:human_genes:S:SCNN1A|SCNN1A]]|-2.22|0.14| |[[:human_genes:A:ALG12|ALG12]]|-2.20|0.14| |[[:human_genes:T:TMEM189-UBE2V1|TMEM189-UBE2V1]]|-2.19|0.14| |[[:human_genes:S:SURF4|SURF4]]|-2.19|0.14| |[[:human_genes:C:COG5|COG5]]|-2.17|0.22| |[[:human_genes:T:TMEM131|TMEM131]]|-2.16|0.22| |[[:human_genes:D:DNAJC3|DNAJC3]]|-2.15|0.15| |[[:human_genes:T:TRPM8|TRPM8]]|-2.11|0.23| |[[:human_genes:C:C2orf53|C2orf53]]|-2.11|0.18| |[[:human_genes:D:DPAGT1|DPAGT1]]|-2.10|0.23| |[[:human_genes:C:CDIPT|CDIPT]]|-2.09|0.49| |[[:human_genes:R:RAD9A|RAD9A]]|-2.09|0.59| |[[:human_genes:N:NFYB|NFYB]]|1.87|0.80| |[[:human_genes:N:NIPBL|NIPBL]]|1.88|0.80| |[[:human_genes:B:BRD8|BRD8]]|1.90|0.80| |[[:human_genes:P:PSMD8|PSMD8]]|1.90|0.80| |[[:human_genes:F:FZD1|FZD1]]|1.90|0.80| |[[:human_genes:P:PI4KB|PI4KB]]|1.91|0.80| |[[:human_genes:N:NRAP|NRAP]]|1.91|0.80| |[[:human_genes:A:ANKRD24|ANKRD24]]|1.92|0.80| |[[:human_genes:C:CDKN1C|CDKN1C]]|1.92|0.80| |[[:human_genes:D:DENR|DENR]]|1.94|0.80| |[[:human_genes:P:PRPF19|PRPF19]]|1.94|0.80| |[[:human_genes:M:MGAT4D|MGAT4D]]|1.95|0.82| |[[:human_genes:I:IQCC|IQCC]]|1.96|0.80| |[[:human_genes:A:ANKRD40|ANKRD40]]|1.96|0.80| |[[:human_genes:S:SHMT2|SHMT2]]|1.97|0.80| |[[:human_genes:P:PSPC1|PSPC1]]|1.97|0.80| |[[:human_genes:C:CYBA|CYBA]]|2.03|0.80| |[[:human_genes:T:TPX2|TPX2]]|2.03|0.80| |[[:human_genes:O:OR4M2|OR4M2]]|2.03|0.80| |[[:human_genes:M:MAU2|MAU2]]|2.06|0.80| |[[:human_genes:G:GAGE2A|GAGE2A]]|2.10|0.80| |[[:human_genes:R:RERG|RERG]]|2.12|0.80| |[[:human_genes:D:DDR2|DDR2]]|2.13|0.80| |[[:human_genes:X:XPO1|XPO1]]|2.17|0.80| |[[:human_genes:H:HSPA12B|HSPA12B]]|2.18|0.80| |[[:human_genes:H:HIST1H2BL|HIST1H2BL]]|2.20|0.80| |[[:human_genes:I:IK|IK]]|2.24|0.80| |[[:human_genes:R:RPS4X|RPS4X]]|2.28|0.80| |[[:human_genes:N:NATD1|NATD1]]|2.29|0.80| |[[:human_genes:P:POLE2|POLE2]]|2.42|0.80| ^Screen^Correlation^Plot^ |[[:results:exp326|CCT251545 20μM R07 exp326]]|0.101|| |[[:results:exp77|Prochlorperazine 5.2μM R02 exp77]]|0.085|| |[[:results:exp149|SB203580 25μM R03 exp149]]|0.078|| |[[:results:exp422|Wiskostatin 3μM R07 exp422]]|0.078|| |[[:results:exp83|Trametinib 10μM R02 exp83]]|0.078|| |[[:results:exp483|FTY720 3μM R08 exp483]]|0.076|| |[[:results:exp344|Chlorpromazine 10μM R07 exp344]]|0.071|| |[[:results:exp538|ZLN024 50μM R08 exp538]]|0.069|| |[[:results:exp530|Thioridazine 5μM R08 exp530]]|0.068|| |[[:results:exp379|MSC2530818 10μM R07 exp379]]|0.066|| |[[:results:exp508|NN-Dimethylsphingosine 2.5μM R08 exp508]]|0.064|| |[[:results:exp293|Myriocin 25μM R06 exp293]]|0.061|| |[[:results:exp537|WNT3A 44ng/ml R08 exp537]]|0.06|| |[[:results:exp490|Hydroxychloroquine 30μM R08 exp490]]|0.059|| |[[:results:exp101|Nicotinamide 1000μM R03 exp101]]|0.059|| |[[:results:exp227|Cryptotanshinone 12μM R05 exp227]]|0.053|| |[[:results:exp47|Lapatinib 5μM R01 exp47]]|0.051|| |[[:results:exp506|Momordin-Ic 10μM R08 exp506]]|0.051|| |[[:results:exp453|B02 10μM R08 exp453]]|0.066|| |[[:results:exp269|Bisphenol A 100μM R06 exp269]]|0.061|| |[[:results:exp461|BS-181 20μM R08 exp461]]|0.059|| {{:chemogenomics:comparison_plots:exp326_vs_exp457.png?nolink |}} {{:chemogenomics:comparison_plots:exp457_vs_exp77.png?nolink |}} {{:chemogenomics:comparison_plots:exp149_vs_exp457.png?nolink |}} {{:chemogenomics:comparison_plots:exp422_vs_exp457.png?nolink |}} {{:chemogenomics:comparison_plots:exp457_vs_exp83.png?nolink |}} {{:chemogenomics:comparison_plots:exp457_vs_exp483.png?nolink |}} {{:chemogenomics:comparison_plots:exp344_vs_exp457.png?nolink |}} {{:chemogenomics:comparison_plots:exp457_vs_exp538.png?nolink |}} {{:chemogenomics:comparison_plots:exp457_vs_exp530.png?nolink |}} {{:chemogenomics:comparison_plots:exp379_vs_exp457.png?nolink |}} {{:chemogenomics:comparison_plots:exp457_vs_exp508.png?nolink |}} {{:chemogenomics:comparison_plots:exp293_vs_exp457.png?nolink |}} {{:chemogenomics:comparison_plots:exp457_vs_exp537.png?nolink |}} {{:chemogenomics:comparison_plots:exp457_vs_exp490.png?nolink |}} {{:chemogenomics:comparison_plots:exp101_vs_exp457.png?nolink |}} {{:chemogenomics:comparison_plots:exp227_vs_exp457.png?nolink |}} {{:chemogenomics:comparison_plots:exp457_vs_exp47.png?nolink |}} {{:chemogenomics:comparison_plots:exp457_vs_exp506.png?nolink |}} {{:chemogenomics:comparison_plots:exp453_vs_exp457.png?nolink |}} {{:chemogenomics:comparison_plots:exp269_vs_exp457.png?nolink |}} {{:chemogenomics:comparison_plots:exp457_vs_exp461.png?nolink |}} ^GO Term^Fold Change^Genes^ |dolichol-linked oligosaccharide biosynthetic process|109.01|ALG9,ALG12,DPAGT1| |oligosaccharide-lipid intermediate biosynthetic process|103.56|ALG9,ALG12,DPAGT1| |phosphotransferase activity, for other substituted phosphate groups|98.62|CEPT1,DPAGT1,CDIPT| |dolichol metabolic process|98.62|ALG9,ALG12,DPAGT1| |polyprenol metabolic process|90.05|ALG9,ALG12,DPAGT1| |endosomal transport|14.88|VPS25,EIPR1,ARL1,VPS52,SURF4| |cellular lipid metabolic process|7.04|ALG9,SCD,ACSL4,KDSR,ADIPOR2,CEPT1,ALG12,DPAGT1,CDIPT| No GO term hits below threshold. (FDR <0.05)